S-100B and Neuron-specific Enolase (NSE) in Spinal Trauma

The Clinical Use of S-100B and NSE in Spinal Cord Injuries

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00980434

Acronym

WBS

Enrollment

Registered

2009-09-21

Start date

2008-02-29

Completion date

2011-12-31

Last updated

2012-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Keywords

vertebral fracture, spinal cord injury

Brief summary

The investigators are studying the clinical worth of the serum markers S-100B and NSE in patients with spinal cord injuries e.g. in patients with vertebral fractures. If there is a injury to the neuronal structures these two proteins could be secreted into the serum and add evidence to the severity of the injury.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Years to No maximum

Healthy volunteers

Inclusion criteria

* vertebral fracture * injuries to the vertebral spine

Exclusion criteria

* head trauma * polytrauma

Design outcomes

Primary

Measure	Time frame
Neurological Symptoms	2 weeks

Countries

Austria

Outcome results